Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany flag Germany · Delayed Price · Currency is EUR
0.0038
+0.0002 (5.56%)
At close: Nov 28, 2025

FRA:9RP Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
51516-
Upgrade
Market Cap Growth
210.35%-69.52%241.44%-76.67%--
Upgrade
Enterprise Value
41302-
Upgrade
Last Close Price
0.000.000.030.050.42-
Upgrade
PS Ratio
66.081.663.32-28.61-
Upgrade
PB Ratio
3.862.211.924.132.76-
Upgrade
P/TBV Ratio
3.862.211.924.132.76-
Upgrade
EV/Sales Ratio
46.780.621.78-10.68-
Upgrade
Asset Turnover
0.050.430.74-0.100.44
Upgrade
Quick Ratio
5.801.966.431.534.496.01
Upgrade
Current Ratio
5.962.076.511.554.546.75
Upgrade
Return on Equity (ROE)
-214.35%-139.56%-75.06%-281.03%-228.75%-106.49%
Upgrade
Return on Assets (ROA)
-119.61%-69.50%-37.84%-118.44%-117.98%-53.00%
Upgrade
Return on Capital (ROIC)
-139.39%-92.96%-52.01%-177.64%-146.61%-64.55%
Upgrade
Return on Capital Employed (ROCE)
-248.00%-346.90%-47.30%-985.10%-183.60%-60.30%
Upgrade
Earnings Yield
-61.78%-147.59%-22.26%-235.76%-64.99%-
Upgrade
FCF Yield
-48.84%-146.14%-26.28%-234.27%-55.99%-
Upgrade
Buyback Yield / Dilution
--115.86%-336.30%-63.10%-104.09%-1.84%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.